Urick also noted that Primes study data was initiated in 2021 and included older products that are no longer used as often, causing the treatment persistence rate to drop to 15%
2018;20(S1):521
When combined with GLP-1 therapy, berberine may provide additive benefits for blood sugar control
About 3 months ago, I introduced a new weight loss medication option, which I also determined to test on myself so I could better advise patients and lose weight again myself
If progress stalls after you reach maintenance, that's worth a conversation with your clinician about dose, diet, and other factors
"But these are not medicines that have been tested in people who don't have overweight and obesity, or Type 2 diabetes." Unexpected benefit The results come after smaller studies and research on animals suggested that GLP-1 drugs could reduce the cravings for specific substances, including alcohol and nicotine